Quintet Private Bank (Europe) S.A. Bio N Tech Se Transaction History
Quintet Private Bank (Europe) S.A.
- $1.72 Trillion
- Q2 2024
A detailed history of Quintet Private Bank (Europe) S.A. transactions in Bio N Tech Se stock. As of the latest transaction made, Quintet Private Bank (Europe) S.A. holds 86 shares of BNTX stock, worth $7,390. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86
Previous 185
53.51%
Holding current value
$7,390
Previous $17.2 Million
60.02%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BNTX
# of Institutions
324Shares Held
40.3MCall Options Held
1.31MPut Options Held
1.37M-
Baillie Gifford & CO8.28MShares$711 Million0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.81MShares$413 Million0.34% of portfolio
-
Harding Loevner LP Bridgewater, NJ3.82MShares$328 Million2.24% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M3.47MShares$298 Million1.4% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U03.43MShares$295 Million1.76% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $20.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...